支架与药物治疗症状性颅内动脉狭窄的对比研究
被引量:4
摘要
动脉粥样硬化性颅内动脉狭窄是缺血性卒中的常见病因[1]。对其进行早期干预和治疗,对预防卒中的复发具有重要的临床意义。
出处
《中国脑血管病杂志》
CAS
2012年第9期483-485,共3页
Chinese Journal of Cerebrovascular Diseases
参考文献12
-
1范常锋,黄一宁.2711例社区居民脑血管狭窄的流行病学调查[J].中华老年心脑血管病杂志,2007,9(1):36-38. 被引量:53
-
2North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis [J]. NEnglJMed,1991,325(7):445453.
-
3陆磊,孙晓江,张进,薛波,施弘.盐酸甲氯芬酯治疗急性脑出血的疗效评价[J].药学服务与研究,2007,7(4):271-273. 被引量:8
-
4Kasner SE, Lynn M J, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID [ J ]. Neurology, 2006, 67 ( 7 ) : 1275-1278.
-
5Kasner SE, Chimowitz MI,Lynn M J, et al. Predictors of is- chemic stroke in the territory of a symptomatic intra cranial arterial stenosis [ J ]. Circulation, 2006,113 ( 4 ) : 555 -563.
-
6Chimowitz MI, Lynn M J, Howlett-Smith H, et al. Com- parison of warfarin and aspirin for symptomatic intracranial arterial stenosis [ J]. N Engl J Med, 2005,352 ( 13 ) : 1305-1316.
-
7Chimowitz MI, Lynn M J, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis [ J ]. N Engl J Med, 2011,365 ( 11 ) : 993-1003.
-
8Meyers PM, Sehumacher HC, Higashida RT, et al. Indi- cations for the performance of intracranial endovascular neurointerventional procedures : a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdiscipli- nary Council on Quality of Care and Outcomes Research r J ]. Circulation. 2009.119 ( 16 ) : 2235-2249.
-
9中国缺血性脑血管病血管内介入诊疗指南[J].中华神经科杂志,2011,44(12):863-869. 被引量:105
-
10The SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial ar- teries ( SSYLVIA ) : study results [ J ]. Stroke, 2004, 35 (6) :1388-1392.
二级参考文献43
-
1冯烈,徐安定,李洁.经颅多普勒超声对糖尿病患者脑血管病变的诊断价值[J].中华内分泌代谢杂志,1994,10(2):86-88. 被引量:116
-
2张天锡,赵卫国,卞留贯.抗自由基与脑损害的防治[J].临床神经外科杂志,2005,2(4):188-190. 被引量:4
-
3张天锡.注射用盐酸甲氯芬酯的临床应用[J].药学服务与研究,2005,5(4):388-390. 被引量:21
-
4张玉麟,王义方.甲氯芬酯治疗轻中度血管性痴呆的临床观察[J].世界临床药物,2007,28(1):40-43. 被引量:3
-
5Barr JD.Cerebral angiography in the assessment of acute cerebral ischemia:guidelines and recommendations.J Vasc Interv Radiol,2004,15:S57-66.
-
6Hacke W,Kaste M,Bluhmki E,et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.N Engl J Med,2008,359:1317-1329.
-
7The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1587.
-
8Hacke W,Kaste M,Fieschi C,et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke:the European Cooperative Acute Stroke Study (ECASS).JAMA,1995,274:1017-1025.
-
9Hacke W,Kaste M,Fieschi C,et al.Second EuropeanAustralasian Acute Stroke Study Investigators.Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous aheplase in acute ischaemic stroke (ECASS Ⅱ).Lancet,1998,352:1245-1251.
-
10Furlan A,Higashida R,Wechsler L,et al.Intra-arterial prourokinase for acute ischemic stroke.The PROACT Ⅱ study:a randomized controlled trial. Prolyse in acute cerebral thromboembolism.JAMA,1999,282:2003-2011.
共引文献163
-
1李燕丽,廖虹,覃桂凤.基底动脉中远段狭窄经颅多普勒检测的临床分析[J].实用医技杂志,2008,15(9):1110-1112. 被引量:1
-
2余传庆,张梅,薛敏,宫琨.缺血性脑血管病患者脑动脉狭窄的分布特征及其危险因素分析[J].神经病学与神经康复学杂志,2010,7(3):142-145. 被引量:18
-
3是明启,侯小艳,王玉洲,郭晖.颈动脉系统短暂性脑缺血发作与颅内外动脉狭窄的相关性研究[J].脑与神经疾病杂志,2011,19(5):384-387. 被引量:2
-
4亢小丽,石进.症状性颅内动脉狭窄血管内支架治疗所面临的问题[J].中国医学前沿杂志(电子版),2012,4(4):11-14. 被引量:1
-
5林小慧,刘开祥,曾爱源,齐立,唐永刚,蒋静子.170例脑梗死患者数字减影血管造影结果分析[J].中国老年学杂志,2014,34(1):196-197. 被引量:5
-
6尚志红.512例缺血性脑血管病患者DSA检查结果分析[J].安徽医学,2013,34(10):1455-1458. 被引量:9
-
7聂亚雄,杨弘文,高帆,阳纲要,林百喜.颅内外血管狭窄增加短暂性脑缺血发作早期的危险[J].中华老年心脑血管病杂志,2008,10(4):280-282. 被引量:4
-
8付铁娟,李贯绯.短暂性脑缺血发作患者颅内外动脉狭窄的分布与预后的相关临床分析[J].中国实验诊断学,2009,13(3):364-366. 被引量:2
-
9李东波,田彦龙,宋冬雷,冷冰,徐斌,顾宇翔,王启弘,陈功,陈亮.120例颅内外脑供血动脉严重狭窄或闭塞患者全脑血管造影分析[J].国际脑血管病杂志,2009,17(2):98-103. 被引量:18
-
10白雪,刘会玲,李韬,王枫.TCD与CTA在颅内动脉狭窄诊断中的比较观察[J].疑难病杂志,2009,8(4):204-206. 被引量:9
同被引文献43
-
1刘一强,杜丽娟,王天玉.血管内介入与单纯药物治疗老年重度颅内前循环动脉狭窄的疗效[J].中国老年学杂志,2015,35(1):70-71. 被引量:10
-
2陶庆玲,孙瑄,赵晖,姚胜旗.颅内动脉狭窄的支架成形术与内科治疗的疗效观察[J].中华神经外科杂志,2006,22(4):233-235. 被引量:36
-
3Lichtenstein MJ, Mulrow CD, Elwood PC. Guidelines for reading case-control studies [J]. J Chronic Dis, 1987, 40 (9): 893-903.
-
4Tang CW, Chang FC, Chem CM, et al. Stenting ver- sus medical treatment for severe symptomatic intracranial stenosis[J]. AJNR Am J Neuroradiol, 2011, 32 (5): 911-916.
-
5Miao Z, Jiang L, V?u H, et al. Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population[J]. Stroke, 2012, 43 (12): 3284-3290.
-
6Qureshi AI, Feldmann E, Gomez CR, et al. Intra- cranial atherosclerotic disease: an update [J]. AnnNeurol, 2009, 66 (6): 730-738.
-
7Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study [J]. Stroke, 1995, 26 (1): 14-20.
-
8Tsai CF, Thomas B, Sudlow CL. Epidemiology of str- oke and its subtypes in Chinese vs white populations: a systematic review[J]. Neurology, 2013, 81 (3): 264-272.
-
9Bose A, Hartmann M, Henkes H, et al. A novel, self- expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study [J]. Stroke, 2007, 38 (5): 1531-1537.
-
10Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results[J]. Stroke, 2007, 38 (3): 881-887.
引证文献4
-
1肖峰,潘剑威,詹仁雅.症状性颅内动脉粥样硬化性狭窄支架辅助治疗疗效评价:基于中国人群的Meta分析[J].中华危重症医学杂志(电子版),2015,8(4):241-245. 被引量:5
-
2陈茹,张念军,赵敏,郭建文,张迎光,马朝晖,陈发军,罗望池,尤劲松,李贵福,蔡业峰,黄燕.支架与药物治疗症状性颅内动脉狭窄远期疗效对比[J].介入放射学杂志,2016,25(2):97-101. 被引量:15
-
3单树崇,黄红莉,周昊,史帝.血管内介入与单纯药物治疗缺血性脑血管病的临床效果比较[J].中国实用医药,2017,12(28):122-124. 被引量:7
-
4姜健楠,高竑,杨华.症状性颅内动脉狭窄治疗方式的研究进展[J].世界最新医学信息文摘,2019,0(8):108-109.
二级引证文献26
-
1孙富文.缺血性脑血管病患者介入治疗的临床效果研究[J].世界最新医学信息文摘,2020(66):6-7. 被引量:1
-
2王菁,解燕昭,刘云娥,秦世杰,朱倩.血管内支架介入与药物治疗症状性颅内动脉粥样硬化性狭窄的临床效果[J].中国医药,2018,13(12):1839-1843. 被引量:15
-
3陈文焰,方凯,梁亚明,曾凡猛.介入手术治疗症状性颅内动脉狭窄的疗效探讨[J].白求恩医学杂志,2016,14(5):596-597. 被引量:1
-
4姚晔,王巍,李琼,张文龙,王嵩.支架成形术治疗老年颈动脉狭窄效果及危险因素分析[J].介入放射学杂志,2016,25(10):839-842. 被引量:9
-
5史方堃.支架置入与药物联合治疗基底动脉重度狭窄患者的疗效比较[J].医疗装备,2017,30(8):1-2.
-
6唐诗玲,曲桂艳.血管内支架置入术与强化药物治疗对症状性颅内动脉狭窄患者远期预后影响的对比研究[J].实用心脑肺血管病杂志,2017,25(9):63-66. 被引量:5
-
7孙玉杰,丁健,张贤军,王乃东,张勇.颅内动脉狭窄部位对支架成形术安全性影响研究[J].中国现代神经疾病杂志,2017,17(11):806-811. 被引量:4
-
8巨涛,宋波,刘文刚,岳新鹏,李鲁,刘增强.颅内动脉支架成形术后再狭窄患者血清miRNA-210,miRNA-126水平检测的临床应用价值[J].现代检验医学杂志,2018,33(3):70-73. 被引量:3
-
9莫金平.症状性颅内动脉粥样硬化性狭窄支架治疗安全性影响因素的研究[J].临床医药文献电子杂志,2018,5(39):98-98.
-
10王菁,解燕昭,刘云娥,秦世杰,朱倩.颅内支架置入术治疗颅内动脉粥样硬化性狭窄近远期疗效观察及再狭窄危险因素分析[J].中国医药导报,2018,15(35):110-113. 被引量:1
-
1马春,李淑婷,华扬,罗玉敏,吉训明.颅内与颅外动脉重度狭窄或闭塞患者血管危险因素的差异[J].中华老年心脑血管病杂志,2011,13(6):521-523. 被引量:8
-
2许斌,徐善才,吴培,刘珍,史怀璋.颅内动脉狭窄血管内治疗的进展[J].中国脑血管病杂志,2011,8(8):441-444. 被引量:7
-
3杨谦,李伟,宋允章,王倩,陈岩,李静艳,刘军.普伐他汀对颅内动脉狭窄的临床疗效分析[J].陕西医学杂志,2011,40(8):953-956. 被引量:1
-
4聂志余,靳令经,刘远洪,陈玉辉,李云霞,郭艳,管强.进展型脑分水岭梗死的临床和影像学特点[J].中华老年心脑血管病杂志,2012,14(12):1285-1288. 被引量:13
-
5王敬凤.可逆性后部白质脑病综合征2例[J].临床荟萃,2012,27(10):912-913.
-
6路文军.皮层下动脉硬化性脑病46例临床分析[J].陕西医学杂志,2007,36(4):455-456. 被引量:1
-
7马敏敏,张仁良,殷勤,徐格林,周志明,朱武生,樊新颖,刘新峰.Wingspan支架治疗症状性颅内动脉狭窄的临床研究[J].中华老年心脑血管病杂志,2009,11(8):564-566. 被引量:4
-
8王艳,王伊龙,吴敌.颅内外动脉狭窄与无狭窄的缺血性脑卒中患者相关危险因素及临床严重程度指标的对比研究[J].临床荟萃,2007,22(19):1418-1419. 被引量:4
-
9邢英琦,高山.经颅彩色多普勒超声对颅内动脉狭窄或闭塞的诊断[J].中国卒中杂志,2010,5(8):657-665. 被引量:6
-
10高雪亮,林浩,白小欣.362例缺血性脑血管病脑血管狭窄与侧支循环特点分析[J].中国介入影像与治疗学,2011,8(1):46-49. 被引量:9